Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
03/2006
03/23/2006WO2006029532A1 Nitrate esters and their use for mitigating cellular damage
03/23/2006WO2005121078A3 Substituted cyclopentene compounds
03/23/2006WO2005120148A3 Compounds derived from lidocaine, pharmaceutical compositions, use and method of treatment, prevention or inhibition of diseases
03/23/2006US20060063843 Compounds for the treatment of inflammatory disorders
03/23/2006US20060063820 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties
03/23/2006CA2580393A1 Dioxolane derivative and method for producing same
03/22/2006EP1637928A2 Photoresist monomer having spiro cyclic ketal group, polymer thereof and photoresist composition including the same
03/22/2006EP1637528A1 Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
03/22/2006EP1637518A2 Inhibitors of aspartyl protease
03/22/2006EP1636200A2 Inhibitors of papilloma virus
03/22/2006EP1636160A2 Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders
03/22/2006EP1635909A2 Treatment of amyloid- and epileptogenesis-associated diseases
03/21/2006US7015345 Propionic acid derivatives
03/21/2006CA2238986C Compounds with isocyanate groups and masked groups reactive in relation to isocyanates
03/16/2006WO2006028733A1 Process for the preparation of z-5-carboxymethylene-1,3-dioxolan-4-ones
03/16/2006WO2006028038A1 Sulfonamide derivative selectively inhibiting mmp-13
03/16/2006WO2006027243A1 Method for reducing alkine compounds
03/16/2006US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
03/16/2006US20060058538 Method for producing an aliphatic dialdehyde monoacetal
03/16/2006US20060058372 N-Benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarboxamide derivatives and pharmaceutical compositions comprising them
03/16/2006US20060058315 2-Oxo-ethanesulfonamide derivates
03/16/2006DE102004044262A1 Verfahren zur katalytischen Reduktion von Alkinverbindungen A process for the catalytic reduction of alkyne compounds
03/16/2006CA2577044A1 Method for reducing alkine compounds
03/15/2006EP1633702A1 Protease inhibitors
03/15/2006EP1633694A2 Substituted indoles and a process for preparing substituted indoles
03/15/2006EP1558624B1 Continuous process for the preparation of fructopyranose sulfamate derivatives
03/15/2006EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/15/2006CN1747946A Method for producing 4-fluoro-1,3-dioxolan-2-one
03/15/2006CN1747711A Melanogenesis inhibitor and skin preparation containing the same
03/15/2006CN1245381C Phenylglycine derivatives
03/15/2006CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives
03/15/2006CN1245370C 3,7-disubstituted-trans-dicyclo[3,3,0] octane compound and its preparation and use
03/14/2006US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders
03/09/2006WO2005060692A3 Biphenyl compounds and methods
03/09/2006US20060052600 Amino-functional chalcones
03/09/2006US20060052445 Diarylsulfones as 5-HT2A antagonists
03/09/2006US20060051879 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
03/08/2006EP1632483A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
03/08/2006EP1632477A1 Benzamide derivative or salt thereof
03/08/2006EP1631542A1 Bicyclic compounds having bradykinin receptors affinity and pharmaceutical compositions thereof
03/08/2006EP1328527B1 Cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including those resistant to usual chemotherapeutic agents and as reversal agents
03/08/2006EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands
03/08/2006EP0736029B1 Anticonvulsant pseudofructopyranose sulfamates
03/08/2006CN1745051A Method for producing alkylene derivative and method for regenerating catalyst for producing alkylene derivative
03/08/2006CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors
03/07/2006US7008636 such as 5'-Octadecyloxy-[1,1';3',1'']terphenyl-2'-yloxy acetic acid for inhibiting Protien-Tyrosine Phosphatases(PTPases) from rat liver microsomes in vitro; for treatment of associated obesity, glucose intolerance, diabetes mellitus, hypertension
03/02/2006WO2006022825A1 Photochromic materials
03/02/2006WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
03/02/2006WO2006021805A1 Diarylsulfones as 5-ht2a antagonists
03/02/2006US20060047129 Process for the preparation of Z-5-carboxymethylene-1,3-dioxolan-4-ones
03/02/2006US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents
03/02/2006CA2577837A1 Diarylsulfones as 5-ht2a antagonists
03/01/2006EP1630161A1 Method of manufacturing alkylene carbonate
03/01/2006EP1233962B1 Novel heterocyclic compounds and their use as medicines
03/01/2006CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
03/01/2006CN1243724C Amide derivatives which are useful as cell factor inhibitors
03/01/2006CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
02/2006
02/23/2006US20060041132 Novel triazolo pyrimidine compounds
02/23/2006US20060041014 Treatment of male sexual dysfunction
02/23/2006US20060041008 Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
02/23/2006DE102004038131A1 Polymerizable or crosslinkable dopants with controllable chiral induction, e.g. useful in liquid crystal displays, comprising 1,3-dioxolane-4,5-dicarboxylic acid derivatives
02/23/2006DE102004034619A1 Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer Substituted amino compounds as 5-HT / NA Uptakehemmer
02/23/2006CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
02/22/2006CN1738811A 1-acetoxy-3-(substituted phenyl) propen compounds preparation method
02/22/2006CN1738794A Biguanide and dihydrotriazine derivatives
02/22/2006CN1737000A Polymer, chemical range enlargement erosion resistant component and forming method
02/22/2006CN1736995A Method for preparing derivatives of baccatin iii
02/21/2006CA2250347C Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors
02/21/2006CA2250258C Novel tetralone or benzopyranone derivatives and process for producing the same
02/21/2006CA2239970C Process for preparing optically active compounds
02/21/2006CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors
02/16/2006WO2005123710A8 Substituted benzoylcyclohexandiones for use as herbicides
02/16/2006WO2005112538A3 Use of adrenergic n-phenylpiperazine antagonists, pharmaceutical compositions containing them, and methods of preparing them.
02/16/2006WO2005080317A3 Therapeutic amide derivatives
02/16/2006WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists
02/16/2006US20060036102 Process for preparing 4-fluoro-1,3-dioxolan-2-one
02/16/2006US20060036096 Process for producing quinolinecarbaldehyde
02/16/2006DE102004032878A1 Verwendung von Alkyloxyalkansäureamiden insbesondere als Aromastoffe sowie neue Alkyloxyalkansäureamide Use of Alkyloxyalkansäureamiden especially as flavorings and new Alkyloxyalkansäureamide
02/15/2006EP1008346B1 NF-kB INHIBITORS CONTAINING BENZOQUINONE DERIVATIVES
02/15/2006CN1733767A Cyclohexanone analog saturated triring(bridge)compound and its preparation method and uses
02/15/2006CN1733756A Vinylene carbonate preparation method
02/15/2006CN1241890C Process for producing 2.7-dimethyl-2,4,6-sarohornene aldehyde mono aldehyde acetal
02/14/2006US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents;
02/14/2006US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic
02/14/2006US6998407 For prophylaxis and therapy of chronic or acute inflammatory or autoimmune diseases, those associated with aberrant lymphocyte or monocyte accumulation such as arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease
02/14/2006CA2363145C Oxamic acids and derivatives as thyroid receptor ligands
02/09/2006WO2006014135A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006WO2006014134A1 Novel piperidine derivative for the treatment of depression
02/09/2006WO2006014012A2 Aromatic compounds
02/09/2006WO2006013399A1 Pharmaceutical intermediates and a process for the preparation thereof
02/09/2006US20060030553 Cell adhesion inhibitors
02/09/2006US20060030543 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease
02/09/2006DE69717294C5 Chinazolin derivate und diese enthaltende pharmazeutische zusammenstellungen Quinazoline derivatives and those containing pharmaceutical assortments
02/09/2006CA2576109A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
02/09/2006CA2576073A1 Novel piperidine derivative for the treatment of depression
02/09/2006CA2573223A1 Aromatic compound
02/08/2006EP1623973A1 Platinum complex
02/08/2006EP1622889A2 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives
02/08/2006EP1622886A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
02/08/2006EP1622860A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 183